These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25934289)
61. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006 [TBL] [Abstract][Full Text] [Related]
62. The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. Huang S Front Biosci; 1999 Jun; 4():D528-32. PubMed ID: 10369808 [TBL] [Abstract][Full Text] [Related]
63. Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma. Lee SH; Lee EH; Lee SH; Lee YM; Kim HD; Kim YZ J Korean Med Sci; 2015 Aug; 30(8):1157-66. PubMed ID: 26240495 [TBL] [Abstract][Full Text] [Related]
64. Structure and function of SET and MYND domain-containing proteins. Spellmon N; Holcomb J; Trescott L; Sirinupong N; Yang Z Int J Mol Sci; 2015 Jan; 16(1):1406-28. PubMed ID: 25580534 [TBL] [Abstract][Full Text] [Related]
65. The role of MAPK signaling pathway in the Her-2-positive meningiomas. Wang Z; Wang W; Xu S; Wang S; Tu Y; Xiong Y; Mei J; Wang C Oncol Rep; 2016 Aug; 36(2):685-95. PubMed ID: 27279438 [TBL] [Abstract][Full Text] [Related]
66. Multifaceted Role of PRDM Proteins in Human Cancer. Casamassimi A; Rienzo M; Di Zazzo E; Sorrentino A; Fiore D; Proto MC; Moncharmont B; Gazzerro P; Bifulco M; Abbondanza C Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290321 [TBL] [Abstract][Full Text] [Related]
67. Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1. Morishita M; di Luccio E Biochem Biophys Res Commun; 2011 Aug; 412(2):214-9. PubMed ID: 21806967 [TBL] [Abstract][Full Text] [Related]
68. Cloning, expression, purification and crystallization of the PR domain of human retinoblastoma protein-binding zinc finger protein 1 (RIZ1). Sun W; Geyer CR; Yang J Int J Mol Sci; 2008 Jun; 9(6):943-950. PubMed ID: 19325838 [TBL] [Abstract][Full Text] [Related]
69. Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT. Stögbauer L; Thomas C; Wagner A; Warneke N; Bunk EC; Grauer O; Canisius J; Paulus W; Stummer W; Senner V; Brokinkel B J Neurosurg; 2021 Sep; 135(3):845-854. PubMed ID: 33307532 [TBL] [Abstract][Full Text] [Related]
70. Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia. Sasaki O; Meguro K; Tohmiya Y; Funato T; Shibahara S; Sasaki T Tohoku J Exp Med; 2002 Mar; 196(3):193-201. PubMed ID: 12002276 [TBL] [Abstract][Full Text] [Related]
71. Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. Dunn J; Ferluga S; Sharma V; Futschik M; Hilton DA; Adams CL; Lasonder E; Hanemann CO EBioMedicine; 2019 Feb; 40():77-91. PubMed ID: 30594554 [TBL] [Abstract][Full Text] [Related]
72. A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. Sorriento D; Campanile A; Santulli G; Leggiero E; Pastore L; Trimarco B; Iaccarino G Mol Cancer; 2009 Nov; 8():97. PubMed ID: 19900276 [TBL] [Abstract][Full Text] [Related]
73. Expression of ZIC family genes in meningiomas and other brain tumors. Aruga J; Nozaki Y; Hatayama M; Odaka YS; Yokota N BMC Cancer; 2010 Mar; 10():79. PubMed ID: 20199689 [TBL] [Abstract][Full Text] [Related]
75. Peptide from Tat basic domain shows striking similarity to a region of human T cell transcription factor 1. Nyhus J; Sommerfelt MA; Sørensen B AIDS Res Hum Retroviruses; 2003 Apr; 19(4):345-6. PubMed ID: 12804007 [No Abstract] [Full Text] [Related]
76. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents. Rajajeyabalachandran G; Kumar S; Murugesan T; Ekambaram S; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S Expert Opin Ther Targets; 2017 Feb; 21(2):145-157. PubMed ID: 28019723 [TBL] [Abstract][Full Text] [Related]
77. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin. Driskell I; Oda H; Blanco S; Nascimento E; Humphreys P; Frye M EMBO J; 2012 Feb; 31(3):616-29. PubMed ID: 22117221 [TBL] [Abstract][Full Text] [Related]
78. Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway. Ge Y; Xu K Cancer Cell Int; 2016; 16():86. PubMed ID: 27895530 [TBL] [Abstract][Full Text] [Related]
79. Holistic and network analysis of meningioma pathogenesis and malignancy. Tao Y; Wei Q; Xu Z; Bai R; Li Y; Luo C; Dong Y; Gao G; Lu Y Biofactors; 2006; 28(3-4):203-19. PubMed ID: 17473381 [TBL] [Abstract][Full Text] [Related]
80. Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis. Robb VA; Li W; Gascard P; Perry A; Mohandas N; Gutmann DH Neurobiol Dis; 2003 Aug; 13(3):191-202. PubMed ID: 12901833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]